Using our patented technology, we are continually working with our clients to develop a wide range of applications for bioprocessing industry where separation of particles and cells is required.
- Cell harvesting from perfusion bioreactores.
- Separation of microcarriers from stem cells.
- Cell cycle synchronization.
- Stem Cell Fractionation/Homogenization for stem cell therapy.
- Protein Product Yield Improvements from reduced use of current filters.
- Exosome harvesting.
- Particulate removal from bioreactors .
- Algae dewatering.
- Antibody production (~ $150 Billion in 2020)
- Cellular/exosome therapy (> $10 Billion in 2020)
- Perfusion bioreactors are the workhorse of all new developments
- Continuous manufacturing is the future of pharma!
- No technology today can easily and cost effectively handle continuous perfusion below 1 litre bioreactor sized.